CaltechAUTHORS
  A Caltech Library Service

Characterization of p97 mutations causing multisystem proteinopathy support a gain-of-function model for pathology

Blythe, E. E. and Martin, A. and Deshaies, R. J. (2017) Characterization of p97 mutations causing multisystem proteinopathy support a gain-of-function model for pathology. Molecular Biology of the Cell, 28 (26). Art. No. M125. ISSN 1059-1524. https://resolver.caltech.edu/CaltechAUTHORS:20180321-142839561

[img] PDF - Published Version
Creative Commons Attribution.

126Kb

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20180321-142839561

Abstract

Valosin‐containing protein (VCP, or p97) is an ATPase essential in numerous protein quality control (PQC) pathways, such as ER‐associated degradation. p97 functions as a segregase, extracting ubiquitylated proteins from membranes or complexes so they can be degraded by the proteasome. However, the complexity of native p97 PQC substrates has stymied the detailed biochemical study of this function. Previously, to address this problem, we developed an in vitro p97 substrate based on an ubiquitin fusion degradation (UFD) pathway substrate, Ub‐GFP, and showed that the unfolding of this substrate by p97 is dependent upon extensive substrate ubiquitylation, the p97 adaptors NPLOC4‐UFD1L, and ATP hydrolysis. Here, we make use of this system, employing an updated version of this substrate, to explore how mutations in p97 that cause multisystem proteinopathy (MSP) affect substrate processing. Previous studies have shown that MSP mutants have higher basal ATP rates than wild type yet cause deficiencies in many p97‐dependent pathways, creating controversy as to whether these dominantly inherited mutations cause disease through a gain‐of‐function or a loss‐of‐function. We have now analyzed seven distinct MSP mutants, all of which showed modestly improved unfolding of our model substrate over wild type p97, providing evidence that the increased ATPase activity leads to a gain‐of‐function. Furthermore, we showed evidence that p97 inhibitors may restore proper p97 function to MSP mutants, suggesting a potential treatment strategy for p97 diseases.


Item Type:Article
Related URLs:
URLURL TypeDescription
https://doi.org/10.1091/mbc.E17-10-0618DOIAbstracts
http://www.molbiolcell.org/content/28/26/3727PublisherAbstracts
ORCID:
AuthorORCID
Deshaies, R. J.0000-0002-3671-9354
Additional Information:© 2017 American Society for Cell Biology. Free via Creative Commons 2 months after publication.
Issue or Number:26
Record Number:CaltechAUTHORS:20180321-142839561
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:20180321-142839561
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:85403
Collection:CaltechAUTHORS
Deposited By: Tony Diaz
Deposited On:26 Mar 2018 21:35
Last Modified:03 Oct 2019 19:30

Repository Staff Only: item control page